For: | Lin WX, Xie YN, Chen YK, Cai JH, Zou J, Zheng JH, Liu YY, Li ZY, Chen YX. Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery. World J Clin Cases 2022; 10(31): 11338-11348 [PMID: 36387832 DOI: 10.12998/wjcc.v10.i31.11338] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i31/11338.htm |
Number | Citing Articles |
1 |
Maidong Li, Xiaofeng Wan, Benjie Shan, Yang He, Chuanrong Chen, Ming Shen. A pH and GSH dual responsive nanoparticle co-deliver Adriamycin and Olaparib enhanced the therapeutic efficacy on triple negative breast cancer. Materials & Design 2025; 256: 114271 doi: 10.1016/j.matdes.2025.114271
|
2 |
Bingye Shi, Wei Zhang, Tao Wang, Zhenyu Cui. The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer. BMC Bioinformatics 2023; 24(1) doi: 10.1186/s12859-023-05348-3
|
3 |
Qiuyu Yang, Liangchen Xi, Mudan Huang, Haosheng Zhang, Fangzheng Zhou. Nomogram for the prediction of the prognosis of patients with triple-negative invasive ductal carcinoma of breast after neoadjuvant chemotherapy. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-05738-y
|